Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. [electronic resource]
Producer: 20160608Description: 966-72 p. digitalISSN:- 1477-0962
- Adolescent
- Agammaglobulinemia -- drug therapy
- Age of Onset
- Anemia, Hemolytic, Autoimmune -- blood
- Antirheumatic Agents -- adverse effects
- B-Lymphocytes -- immunology
- Child
- Cohort Studies
- Female
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Immunophenotyping
- Lupus Erythematosus, Systemic -- blood
- Male
- Purpura, Thrombocytopenic, Idiopathic -- blood
- Remission Induction
- Retrospective Studies
- Rituximab -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.